To provide a more in-depth look at the current healthcare spotlight on medications such as Ozempic, Wegovy, Mounjaro, and Zepbound, we have created a series of episodes that go beyond the headlines. In our first episode, we are joined by Dr. Carolyn Jasik, Chief Medical Officer at Omada Health. She provides us with insights into the science of satiety, the perspectives of obesity-focused physicians, and the lifestyle implications that patients on these medications may face.
Our series aims to offer a better understanding of what anti-obesity medications are, where they are headed in the future, and the obstacles that need to be addressed along the way. Through these conversations, we hope to shed light on the complexities surrounding these treatments and their impact on patients’ lives. The healthcare community is constantly evolving, and it’s essential to stay informed about new developments in this field.
